Northern Trust Corp Dr Reddys Laboratories LTD Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Northern Trust Corp holds 75,206 shares of RDY stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,206

Previous 76,114 1.19%

Holding current value

$1.16 Million

Previous $5.8 Million 3.04%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$75.41 - $84.21 $68,472 - $76,462	-908 Reduced 1.19%	75,206 $5.98 Million
Q2 2024 Aug 14, 2024	BUY	$68.26 - $76.19 $642,463 - $717,100	9,412 Added 14.11%	76,114 $5.8 Million
Q1 2024 May 14, 2024	BUY	$67.36 - $77.59 $1.97 Million - $2.27 Million	29,192 Added 77.82%	66,702 $4.89 Million
Q4 2023 Feb 13, 2024	SELL	$64.27 - $69.9 $313,573 - $341,042	-4,879 Reduced 11.51%	37,510 $2.61 Million
Q3 2023 Nov 13, 2023	SELL	$61.9 - $72.77 $555,862 - $653,474	-8,980 Reduced 17.48%	42,389 $2.83 Million
Q2 2023 Aug 11, 2023	BUY	$53.34 - $63.11 $1.61 Million - $1.9 Million	30,092 Added 141.43%	51,369 $3.24 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $19,929 - $21,974	386 Added 1.85%	21,277 $1.21 Million
Q4 2022 Feb 13, 2023	SELL	$51.15 - $57.45 $45,574 - $51,187	-891 Reduced 4.09%	20,891 $1.08 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $34,680 - $39,837	-695 Reduced 3.09%	21,782 $1.14 Million
Q2 2022 Aug 12, 2022	SELL	$49.62 - $58.13 $145,336 - $170,262	-2,929 Reduced 11.53%	22,477 $1.24 Million
Q1 2022 May 13, 2022	SELL	$48.27 - $65.25 $160,980 - $217,608	-3,335 Reduced 11.6%	25,406 $1.42 Million
Q4 2021 Feb 08, 2022	SELL	$59.5 - $67.25 $1.16 Million - $1.31 Million	-19,447 Reduced 40.36%	28,741 $1.88 Million
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $24.5 Million - $30.7 Million	-407,776 Reduced 89.43%	48,188 $3.14 Million
Q2 2021 Aug 13, 2021	BUY	$62.12 - $74.2 $2.17 Million - $2.59 Million	34,938 Added 8.3%	455,964 $33.5 Million
Q1 2021 May 12, 2021	SELL	$57.98 - $73.08 $5.41 Million - $6.82 Million	-93,351 Reduced 18.15%	421,026 $25.8 Million
Q4 2020 Feb 11, 2021	BUY	$62.61 - $71.29 $416,857 - $474,648	6,658 Added 1.31%	514,377 $36.7 Million
Q3 2020 Nov 16, 2020	BUY	$51.39 - $72.41 $3.38 Million - $4.76 Million	65,799 Added 14.89%	507,719 $35.3 Million
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $21,515 - $29,729	544 Added 0.12%	441,920 $23.4 Million
Q1 2020 May 14, 2020	BUY	$34.75 - $45.85 $859,819 - $1.13 Million	24,743 Added 5.94%	441,376 $17.8 Million
Q4 2019 Feb 14, 2020	SELL	$36.66 - $41.78 $628,242 - $715,983	-17,137 Reduced 3.95%	416,633 $16.9 Million
Q3 2019 Nov 13, 2019	SELL	$34.82 - $39.26 $748,107 - $843,501	-21,485 Reduced 4.72%	433,770 $16.4 Million
Q2 2019 Aug 13, 2019	SELL	$36.05 - $42.76 $342,150 - $405,835	-9,491 Reduced 2.04%	455,255 $17.1 Million
Q1 2019 May 13, 2019	BUY	$35.77 - $40.57 $1.78 Million - $2.01 Million	49,660 Added 11.96%	464,746 $18.8 Million
Q4 2018 Feb 12, 2019	BUY	$31.89 - $38.44 $490,946 - $591,783	15,395 Added 3.85%	415,086 $15.6 Million
Q3 2018 Nov 14, 2018	BUY	$29.25 - $36.73 $567,654 - $712,819	19,407 Added 5.1%	399,691 $13.8 Million
Q2 2018 Sep 18, 2018	SELL	$28.49 - $35.06 $308,603 - $379,769	-10,832 Reduced 2.77%	380,284 $12.2 Million
Q2 2018 Aug 14, 2018	BUY	$28.49 - $35.06 $809,999 - $996,790	28,431 Added 7.84%	391,116 $12.6 Million
Q1 2018 May 09, 2018	BUY	$31.93 - $39.54 $3.77 Million - $4.67 Million	118,157 Added 48.32%	362,685 $11.9 Million
Q4 2017 Feb 14, 2018	SELL	$34.15 - $37.62 $885,270 - $975,223	-25,923 Reduced 9.59%	244,528 $9.19 Million
Q3 2017 Nov 13, 2017	BUY	$30.11 - $37.72 $8.14 Million - $10.2 Million	270,451	270,451 $9.65 Million

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Dr Reddys Laboratories LTD Transaction History